Sumitomo Pharma Co., Ltd. (FRA:DPM)

Germany flag Germany · Delayed Price · Currency is EUR
12.30
-0.60 (-4.65%)
At close: Jan 28, 2026
251.43%
Market Cap4.98B +269.2%
Revenue (ttm)2.46B +21.6%
Net Income598.04M
EPS1.51
Shares Outn/a
PE Ratio8.32
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volume570
Open12.30
Previous Close12.90
Day's Range12.30 - 12.30
52-Week Range3.00 - 16.80
Betan/a
RSI43.55
Earnings DateJan 30, 2026

About Sumitomo Pharma

Sumitomo Pharma Co., Ltd. Manufactures, purchases, and sells pharmaceutical products for medical treatment in Japan, North America, and Asia. It offers therapeutic agents for parkinson’s disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. The company also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, it offers veterinary medicines, medical devices, etc. The company has coll... [Read more]

Industry Pharmaceutical Preparations
Founded 1897
Employees 3,832
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol DPM
Full Company Profile

Financial Performance

Financial numbers in JPY Financial Statements